These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 138999

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Preservation of in vitro biological functions in regional lymph node lymphocytes in squamous head and neck cancer.
    Saxon A, Portaro J.
    Cancer Res; 1977 Apr; 37(4):1159-64. PubMed ID: 139203
    [Abstract] [Full Text] [Related]

  • 4. Cellular immune response in squamous cell carcinomas of head and neck: evaluation by histological indices.
    Ariz M, Ahmad KN, Khan AA, Hasan SA.
    Indian J Pathol Microbiol; 1986 Oct; 29(4):392-9. PubMed ID: 3817970
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transference of cell mediated immunity in patients with head and neck cancer.
    Vetto RM, Burger DR.
    Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):79-82. PubMed ID: 304143
    [Abstract] [Full Text] [Related]

  • 9. Total lymphocyte and T lymphocyte subpopulation levels in head and neck squamous cell carcinomas.
    Soysal V, Yigitbasi OG, Alper M, Patiroglu T, Güney E.
    J Exp Clin Cancer Res; 1998 Jun; 17(2):207-12. PubMed ID: 9700582
    [Abstract] [Full Text] [Related]

  • 10. Assessment of immunocompetent cells in patients with head and neck squamous cell carcinoma.
    Dawson DE, Everts EC, Vetto RM, Burger DR.
    Ann Otol Rhinol Laryngol; 1985 Jun; 94(4 Pt 1):342-5. PubMed ID: 3875306
    [Abstract] [Full Text] [Related]

  • 11. Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma.
    Wolf GT, Carey TE.
    J Natl Cancer Inst Monogr; 1992 Jun; (13):67-74. PubMed ID: 1389697
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM, Heo DS, Okarma T, Johnson JT, Herberman RB, Whiteside TL.
    Cancer Res; 1991 Aug 01; 51(15):3891-9. PubMed ID: 1677310
    [Abstract] [Full Text] [Related]

  • 14. The relationship of circulating IgA to cellular immunity in head and neck cancer patients.
    Schantz SP, Liu FJ, Taylor D, Beddingfield N, Weber RS.
    Laryngoscope; 1988 Jun 01; 98(6 Pt 1):671-8. PubMed ID: 3259661
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Effects of radiotherapy on cellular immunity of patients with head and neck cancers].
    Misaki T, Arai K, Konishi J, Abe M, Torizuka K, Makimoto K, Nesumi N.
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec 20; 21(10):2371-6. PubMed ID: 3494798
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An immunological outcome predictive score for head and neck carcinoma patients.
    Kaffenberger W, Hölzer-Müller L, Auberger T, Clasen BP, Hohlmeier G, van Beuningen D.
    Strahlenther Onkol; 1995 Aug 20; 171(8):444-53. PubMed ID: 7652667
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.